Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Development and Validation of a Multiplex Non-HLA Antibody Assay for the Screening of Kidney Transplant Recipients.

Kamburova EG, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Meeldijk J, Bovenschen N, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Front Immunol. 2018 Dec 19;9:3002. doi: 10.3389/fimmu.2018.03002. eCollection 2018.

2.

Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells.

Bengsch B, Ohtani T, Khan O, Setty M, Manne S, O'Brien S, Gherardini PF, Herati RS, Huang AC, Chang KM, Newell EW, Bovenschen N, Pe'er D, Albelda SM, Wherry EJ.

Immunity. 2018 May 15;48(5):1029-1045.e5. doi: 10.1016/j.immuni.2018.04.026.

PMID:
29768164
3.

Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma.

Vermeulen JF, Van Hecke W, Adriaansen EJM, Jansen MK, Bouma RG, Villacorta Hidalgo J, Fisch P, Broekhuizen R, Spliet WGM, Kool M, Bovenschen N.

Oncoimmunology. 2017 Nov 27;7(3):e1398877. doi: 10.1080/2162402X.2017.1398877. eCollection 2018.

4.

Systemic and local granzyme B levels are associated with disease activity, kidney damage and interferon signature in systemic lupus erythematosus.

Kok HM, van den Hoogen LL, van Roon JAG, Adriaansen EJM, Fritsch-Stork RDE, Nguyen TQ, Goldschmeding R, Radstake TRDJ, Bovenschen N.

Rheumatology (Oxford). 2017 Dec 1;56(12):2129-2134. doi: 10.1093/rheumatology/kex332.

PMID:
28968826
5.

Oncogenic role of cytomegalovirus in medulloblastoma?

Hortal AM, Vermeulen JF, Van Hecke W, Bovenschen N.

Cancer Lett. 2017 Nov 1;408:55-59. doi: 10.1016/j.canlet.2017.08.024. Epub 2017 Aug 24. Review.

6.

Connective tissue growth factor regulates fibrosis-associated renal lymphangiogenesis.

Kinashi H, Falke LL, Nguyen TQ, Bovenschen N, Aten J, Leask A, Ito Y, Goldschmeding R.

Kidney Int. 2017 Oct;92(4):850-863. doi: 10.1016/j.kint.2017.03.029. Epub 2017 May 23.

PMID:
28545716
7.

Deep immune profiling by mass cytometry links human T and NK cell differentiation and cytotoxic molecule expression patterns.

Bengsch B, Ohtani T, Herati RS, Bovenschen N, Chang KM, Wherry EJ.

J Immunol Methods. 2018 Feb;453:3-10. doi: 10.1016/j.jim.2017.03.009. Epub 2017 Mar 19.

8.

A novel proinflammatory role for granzyme A.

van Eck JA, Shan L, Meeldijk J, Hack CE, Bovenschen N.

Cell Death Dis. 2017 Feb 23;8(2):e2630. doi: 10.1038/cddis.2017.56. No abstract available.

9.

Differences in T-cell infiltrates and survival between HPV+ and HPV- oropharyngeal squamous cell carcinoma.

Matlung SE, Wilhelmina van Kempen PM, Bovenschen N, van Baarle D, Willems SM.

Future Sci OA. 2016 Jan 7;2(1):FSO88. doi: 10.4155/fso.15.88. eCollection 2016 Mar. Review.

10.

Granzymes A and K differentially potentiate LPS-induced cytokine response.

Wensink AC, Kok HM, Meeldijk J, Fermie J, Froelich CJ, Hack CE, Bovenschen N.

Cell Death Discov. 2016 Dec 12;2:16084. doi: 10.1038/cddiscovery.2016.84. eCollection 2016.

11.

Proteomic profiling of the spinal cord in ALS: decreased ATP5D levels suggest synaptic dysfunction in ALS pathogenesis.

Engelen-Lee J, Blokhuis AM, Spliet WGM, Pasterkamp RJ, Aronica E, Demmers JAA, Broekhuizen R, Nardo G, Bovenschen N, Van Den Berg LH.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):210-220. doi: 10.1080/21678421.2016.1245757. Epub 2016 Nov 29.

PMID:
27899032
12.

Rapid hepatic clearance of full length CCN-2/CTGF: a putative role for LRP1-mediated endocytosis.

Gerritsen KG, Bovenschen N, Nguyen TQ, Sprengers D, Koeners MP, van Koppen AN, Joles JA, Goldschmeding R, Kok RJ.

J Cell Commun Signal. 2016 Dec;10(4):295-303. Epub 2016 Sep 19.

13.

No evidence for human cytomegalovirus infection in pediatric medulloblastomas.

Vermeulen JF, van Hecke W, Jansen MK, Spliet WG, Broekhuizen R, Bovenschen N.

Neuro Oncol. 2016 Oct;18(10):1461-2. doi: 10.1093/neuonc/now151. Epub 2016 Aug 12. No abstract available.

14.

Biological responses of human solid tumor cells to X-ray irradiation within a 1.5-Tesla magnetic field generated by a magnetic resonance imaging-linear accelerator.

Wang L, Hoogcarspel SJ, Wen Z, van Vulpen M, Molkentine DP, Kok J, Lin SH, Broekhuizen R, Ang KK, Bovenschen N, Raaymakers BW, Frank SJ.

Bioelectromagnetics. 2016 Oct;37(7):471-80. doi: 10.1002/bem.21991. Epub 2016 Jul 19.

PMID:
27434783
15.

Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.

van Kempen PM, Noorlag R, Swartz JE, Bovenschen N, Braunius WW, Vermeulen JF, Van Cann EM, Grolman W, Willems SM.

Cancer Immunol Immunother. 2016 May;65(5):575-85. doi: 10.1007/s00262-016-1819-4. Epub 2016 Mar 18.

16.

Reduced serpinB9-mediated caspase-1 inhibition can contribute to autoinflammatory disease.

van der Burgh R, Meeldijk J, Jongeneel L, Frenkel J, Bovenschen N, van Gijn M, Boes M.

Oncotarget. 2016 Apr 12;7(15):19265-71. doi: 10.18632/oncotarget.8086.

17.

Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme Inhibitors.

Vermeulen JF, van Hecke W, Spliet WG, Villacorta Hidalgo J, Fisch P, Broekhuizen R, Bovenschen N.

PLoS One. 2016 Mar 10;11(3):e0151465. doi: 10.1371/journal.pone.0151465. eCollection 2016.

18.

Granzyme M and K release in human experimental endotoxemia.

Wensink AC, Wiewel MA, Jongeneel LH, Boes M, van der Poll T, Hack CE, Bovenschen N.

Immunobiology. 2016 Jul;221(7):773-7. doi: 10.1016/j.imbio.2016.02.006. Epub 2016 Feb 24.

19.

Bioluminescent reporters to monitor killer cell-mediated delivery of granzymes inside target cells.

de Poot SA, van Erp EA, Meeldijk J, Broekhuizen R, Goldschmeding R, Olthof MC, Steeghs EM, Bovenschen N.

Blood. 2015 Dec 24;126(26):2893-5. doi: 10.1182/blood-2015-07-657841. Epub 2015 Nov 13. No abstract available.

20.

Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting.

Meyer S, Nederend M, Jansen JH, Reiding KR, Jacobino SR, Meeldijk J, Bovenschen N, Wuhrer M, Valerius T, Ubink R, Boross P, Rouwendal G, Leusen JH.

MAbs. 2016;8(1):87-98. doi: 10.1080/19420862.2015.1106658. Epub 2015 Oct 14. Erratum in: MAbs. 2017 Jan;9(1):165.

Supplemental Content

Loading ...
Support Center